Integrata

Dr. Chantelle Thomas speaks with Dr. Daniel Zimmerman and Heather Hamilton of in lower Manhattan about the evolution of ketamine-assisted psychotherapy (KAP) in their practice and in the broader field. They trace their entry into psychedelic medicine, discuss the shift from symptom-focused treatment toward insight-oriented psychotherapy, and explore dosing philosophy, music, risk, and the influence of practicing in New York City. The conversation balances enthusiasm with caution, emphasizing pacing, integration, and ethical humility in a rapidly expanding field.

(09:29) Ketamine as Catalyst — Moving beyond symptom management toward medicine-assisted psychotherapy.
(26:58) Dosing and Risk — IM vs lozenge, high-dose concerns, and integration pacing.
(40:07) Music and Setting — Curated playlists and environment as therapeutic container.
(46:55) The New York Context — Speed, ambition, trauma history, and slowing down.
(53:59) Group KAP — Community healing and expanding into intentional group work.

Listen at windroserecovery.com/podcast or wherever you get your podcasts

This Friday at the UW Madison Psychedelic Symposium, Dr. Chantelle Thomas will discuss some of the most pertinent and pressing issues around psychedelic assisted therapy and the current compounds available for therapeutic use. Following will be a panel discussion with experts from around the country. Our Integrata team will also be exhibiting so be sure to visit our booth!

Check out the conference here to register: https://ce.pharmacy.wisc.edu/pd/uw-madison-psychedelic-symposium-2/

If you're attending this year's Trauma & Addictions Conference, make sure to catch Dr. Thomas's presentation on psychedelic assisted psychotherapy for addiction & co-occurring disorders!

This presentation is your gateway to uncovering the potential of these psychedelic assisted therapies as adjunctive tools for treating addiction and other co-occurring disorders. It will highlight clients who may be appropriate for this treatment and explore the potential risks and opportunities of using psychedelics for therapeutic purposes.

As the closing session on the first full day of the main conference, you won't want to miss it!
With in-person and virtual options for attending, you can even catch the replay.

Visit the link below and use the code 50TNA if you haven't registered!
https://www.pekf93j.com/3NKHWHB/P66JJ4/

Are you searching for new and better ways to serve your patients with some of the most devastating mental health conditions, such as addiction, PTSD, and treatment-resistant depression?

Dr. Chantelle Thomas, Executive Clinical Director at Integrata, will review what clinical research has taught us about the potential impact of Ketamine on the symptoms of individuals suffering across various mental health conditions.
Many people may not be aware of the wide range of Ketamine's subjective effects and varied experiences occasioned from different dosage, route of administration, and contextual factors. In this regard, Dr. Thomas will be sharing her first-hand knowledge and expertise.

Dr. Thomas' session will be part of the 2023 Sana Symposium, taking place on Thursday, October 26th, from 1:45 PM - 2:45 PM. The 2023 Sana Symposium for Psychedelics Education for Mental Health & Addiction Professionals is scheduled for October 26th and 27th is a wonderful opportunity for education among mental health and addiction professionals. To find out more, visit the Sana Symposium website: sanasymposium.com